---
title: "Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300485.SZ.md"
symbol: "300485.SZ"
name: "Beijing Science Sun Pharmaceutical Co.,Ltd."
industry: "Biotechnology"
datetime: "2026-05-21T10:16:02.789Z"
locales:
  - [en](https://longbridge.com/en/quote/300485.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300485.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300485.SZ.md)
---

# Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ)

## Company Overview

Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese medicine; manufacture of Chinese and Western medicine preparations; research, development, production, and sales of tablets, hard capsules, powders, granules, and active pharmaceutical ingredients; outward investment, technology introduction and exchange, international business development, livestock and poultry production, and research and development of bio-organic fertilizers and bio-feeds. In addition, the company is engaged venture capital; equity investment through private equity funds; technology development, transfer, and services for biological products, pharmaceuticals, diagnostic reagents, and medical devices; biotechnology information consulting; sales of immunoassay reagents and laboratory instruments; research, development and industrialization of human vaccines; investment management and consulting for non-securities businesses, as well as inspection and testing services, consulting services, and health food production.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | CN Market |
| Website | [www.ssyy.com.cn](https://www.ssyy.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: C (0.56)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 51 / 81 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.79% |  |
| Net Profit YoY | -112.82% |  |
| P/B Ratio | 1.38 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4639145291.29 |  |
| Revenue | 401846837.86 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -0.61% | D |
| Profit Margin | -5.15% | D |
| Gross Margin | 68.11% | A |
| Revenue YoY | 0.79% | C |
| Net Profit YoY | -112.82% | E |
| Total Assets YoY | -0.63% | D |
| Net Assets YoY | -0.83% | D |
| Cash Flow Margin | -131.88% | E |
| OCF YoY | 0.79% | C |
| Turnover | 0.11 | E |
| Gearing Ratio | 4.76% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Beijing Science Sun Pharmaceutical Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.79%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-112.82%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.38",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4639145291.29",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "401846837.86",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-0.61%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-5.15%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "68.11%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "0.79%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-112.82%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.63%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.83%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-131.88%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "0.79%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.11",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "4.76%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -224.16 | 78/81 | 72.13 | 65.96 | 43.87 |
| PB | 1.38 | 11/81 | 1.88 | 1.63 | 1.54 |
| PS (TTM) | 11.54 | 55/81 | 15.99 | 13.82 | 13.03 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Sunshine Guojian Pharmaceutical (688336.SH) | A | A | B | A | B | A |
| 02 | AMOYTOP (688278.SH) | A | A | A | A | B | A |
| 03 | BeOne Medicines (688235.SH) | B | A | B | C | A | B |
| 04 | RemeGen (688331.SH) | A | A | C | C | B | B |
| 05 | InnoCare Pharma (688428.SH) | B | A | D | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300485.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300485.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300485.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300485.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**